Lilly Buys Psychedelics Maker Atai Beckley for $2.8B
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
This analysis contrasts zero-based budgeting with traditional budgeting, outlining when each method reduces waste and improves clarity.
22,489 articlesEli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
As Gap readies its (gap) 2025 earnings call, investors want clarity on brand performance, margins, and 2026 guidance....
As 2026 unfolds, retirees face a pivotal choice: claim at Full Retirement Age or delay. The unfortunate truth about c...
Alphabet and Meta are steering through a redefining ad market shaped by AI investment. This piece compares valuation,...
A year after taking the helm at Stellantis, Antonio Filosa faces a mixed bag: a Q1 2026 earnings beat, a historic 202...
A hypothetical $10,000 investment in Lockheed Martin at the Iran conflict’s start would be down about 22% by late Apr...
When Micron stock sinks today, it isn’t just one factor at play. This guide breaks down the drivers, how to read the ...
As CI&T launches into 2026, investors are scanning for momentum, margin resilience, and strategic bets. This deep div...
As AI accelerates, the Microsoft-OpenAI relationship faces shifts. This piece explains why microsoft distancing itsel...
Retirees are rethinking a longtime rule of thumb: pay off the mortgage before retirement. With rates higher and marke...
Korean chip equities are wavering after a blistering AI-driven rally, with the KOSPI retreating and memory peers weig...
NIO and LI AUTO report divergent Q3 2025 results: NIO accelerates with a multi-brand push, while LI AUTO trims extend...